Opiant Pharmaceuticals Inc (OQ:OPNT)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
Allakos (OQ:ALLK)
BioMarin Pharmaceutical (OQ:BMRN)
Latest 10 SEC filings (by transaction date) for OPNT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 2/19 Jul 2/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -2,195 $13.16
Jul 2/19 Jul 1/19 Skolnick Phil Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Jul 2/19 Jul 1/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -7,805 $13.20
Jul 2/19 Jul 1/19 Skolnick Phil Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $9.00
Jun 13/19 Jun 12/19 Thomas Thomas T. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 2,500  
Jun 13/19 Jun 12/19 Daly Richard J Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 2,500  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for OPNT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 21st, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 11/19 Jul 11/19 Ellison Mark Jason Heath Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 2/19 Jul 1/19 Skolnick Phil Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -10,000  
Jul 2/19 Jul 2/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -2,195 $13.16
Jul 2/19 Jul 1/19 Skolnick Phil Direct Ownership Common Stock S - Open market or private sale -7,805 $13.20
Jul 2/19 Jul 1/19 Skolnick Phil Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,000 $9.00
Jun 13/19 Jun 12/19 Thomas Thomas T. Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 2,500  
Jun 13/19 Jun 12/19 Daly Richard J Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 2,500  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $OPNT

StockTwits